Maria Gomes-Solecki, DVM
858 Madison Ave.
301 Molecular Science Building
Memphis, TN 38163
My research interests arise from milestone driven fundamental research where I am inspired to make basic discoveries in the laboratory and apply them to alleviate human disease. Walking the line between academia and industry I pursue basic research at the University funded through the NIH RO1 and UO1 mechanisms and when applicable I translate these discoveries into vaccines and diagnostics against infectious diseases funded through the NIH SBIR program.
Work in my laboratory focuses on the development of oral vaccine delivery vehicles using commensal bacteria (i.e. Lactobacillus spp. and E. coli) capable of inducing protective immune responses against microbial pathogens and that can counteract the immune disregulation that leads to autoimmune diseases. We use a number of tools (microbiology, molecular biology and immunology) to investigate innate and adaptive immune mechanisms of protection (Th1, Th2, Th17 and Treg). Major projects relate to the development of reservoir targeted vaccines against spirochetal diseases, such as Lyme disease and Leptospirosis.
MGS Federal Funding
MGS Service 2012
NIH Study Section RO1: “Partnerships for Development of Vaccine Technologies (RO1)” ZAI1-SM-M-J1 October 2012
NIH Study Section Small Business: “Non-HIV Diagnostics, Food Safety, Sterilization/Disinfection and Bioremediation Special Emphasis Panel” ZRG1 IDM-V(12) March 2012/November 2012.
Polish National Science Center, Poland. Grants Peer Reviewer. June 2012.
- Postdoc, SUNY at Stony Brook, 1995-1998
- Fellowship, National Institute of Technology (Lisbon, Portugal), 1992-1995
- DVM, University of Lisbon, 1992